<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref94">
 <mixed-citation publication-type="journal" id="cit94">
  <name>
   <surname>Xia</surname>
   <given-names>S.</given-names>
  </name>; 
  <name>
   <surname>Xu</surname>
   <given-names>W.</given-names>
  </name>; 
  <name>
   <surname>Wang</surname>
   <given-names>Q.</given-names>
  </name>; 
  <name>
   <surname>Wang</surname>
   <given-names>C.</given-names>
  </name>; 
  <name>
   <surname>Hua</surname>
   <given-names>C.</given-names>
  </name>; 
  <name>
   <surname>Li</surname>
   <given-names>W.</given-names>
  </name>; 
  <name>
   <surname>Lu</surname>
   <given-names>L.</given-names>
  </name>; 
  <name>
   <surname>Jiang</surname>
   <given-names>S.</given-names>
  </name>
  <article-title>Peptide-based membrane fusion inhibitors targeting hcov-229e spike protein HR1 and HR2 domains</article-title>. 
  <source>Int. J. Mol. Sci.</source>
  <year>2018</year>, 
  <volume>19</volume>, 
  <fpage>487</fpage>
  <pub-id pub-id-type="doi">10.3390/ijms19020487</pub-id>.
 </mixed-citation>
</ref>
